e-learning
resources
London 2016
Monday, 05.09.2016
Latent tuberculosis infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Özlem Salman Sever (Ankara, Turkey), Özlem Salman Sever, Balam Er Dedekarginoglu, Mahal Alekberov, Fusun Oner Eyupoglu
Source:
International Congress 2016 – Latent tuberculosis infection
Session:
Latent tuberculosis infection
Session type:
Oral Presentation
Number:
3042
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Özlem Salman Sever (Ankara, Turkey), Özlem Salman Sever, Balam Er Dedekarginoglu, Mahal Alekberov, Fusun Oner Eyupoglu. The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection. Eur Respir J 2016; 48: Suppl. 60, 3042
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Related content which might interest you:
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Latent TB infection in health care TB workers
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
Contribution of the T-SPOT.TB assay for differentiating active
versus
latent tuberculosis infection (LTBI)
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
QuantiFERON-TB GIT (QFT-GIT)
vs
TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept